Wednesday, February 2, 2011

February is Heart Health month - Dave Barton, director of education, Enzymedica

The enzyme nattokinase, extracted from a Japanese fermented soy bean called natto (which also contains vitamin K2), has been the subject of research into its high fibrinolytic activity (the breaking down of fibrin, the blood clotting protein) and antioxidant activity, according to Dave Barton, director of education, Enzymedica, Port Charlotte, FL.

One such study involving nattokinase was conducted on Japanese volunteers. “The tests indicated that nattokinase generated a heightened ability to support circulation. On average, the volunteers’ ELT (Euglobulin lysis time, a measure of how long it takes to dissolve a blood clot) dropped by 48% within two hours of treatment. An additional study showed an 11% decrease in blood pressure after just two weeks,” Barton says (2)

No comments:

Post a Comment